Actively Recruiting
Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease
Led by Centre intégré de santé et de services sociaux de l'Outaouais · Updated on 2026-05-13
26
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will evaluate whether a wearable robotic exoskeleton can improve mobility, balance, and walking in healthy older adults and in individuals living with Parkinson's disease, populations at high risk of falls and mobility limitations. Participants will attend two laboratory sessions. The first session includes clinical assessments, fitting and familiarization with the exoskeleton, and interviews to explore user perceptions. The second session involves performing functional mobility tasks (e.g., walking, standing, turning) with and without the exoskeleton and under different assistance levels, while movement is measured using wearable sensors. The study will assess the immediate effects of the exoskeleton on mobility, compare assistance levels, identify which participants benefit most, and explore user experience and acceptability. Findings will help inform the development and implementation of assistive technologies to support mobility in healthy aging and in individuals with Parkinson's disease.
CONDITIONS
Official Title
Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to walk for at least 30 minutes with or without minimal aid
- Diagnosis of idiopathic Parkinson's disease (for Parkinson's group)
- Hoehn and Yahr stage 1 to 4 (for Parkinson's group)
- Age 65 years or older (for healthy elderly group)
You will not qualify if you...
- Height smaller than 152 cm
- Severe vascular conditions of the lower limbs that may limit mobility or pose a risk
- Presence of any implantable or external life-sustaining medical device such as a pacemaker
- Severe osteoporosis or high risk of fractures
- Contraindication to the required physical effort
- Severe cognitive impairment (MoCA score less than 21)
- Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility, other than Parkinson's disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
TechCare Research Lab - CISSS de l'Outaouais
Gatineau, Quebec, Canada, J9H 3Z1
Actively Recruiting
Research Team
A
Alexandra Potvin-Desrochers, PhD
CONTACT
L
Lucas Michaud, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here